MEPs voted to adopt their negotiating position on the controversial reform, but it will not be finalised until after the European elections in June. Despite concessions, the pharma industry is not happy
The new law is intended to allow EU citizens to access their health records when in any member state, and to choose whether or not to allow anonymized data to be shared for secondary use in research and public health
After long negotiations MEPs agreed on the EU’s pharmaceutical reform. It includes longer exclusivity for data filed to get marketing approval for new drugs. But pharma still isn’t happy
In the wake of an espionage scandal, a former vice rector of the University of Tartu examines how universities across the EU have become targets in Russia’s hybrid war - and how they should defend themselves
The creation of the European Health Data Space is in the balance, with talks between the Parliament and Council set to continue on Thursday, in a bid to agree a deal before the EU elections
Data centers make a notoriously large contribution to greenhouse gas emissions. But a call to slow down research in a bid to reduce their environmental impact makes no sense - sustainability can go hand-in-hand with increased processing power
European Digital Infrastructure Consortia will help countries to pool resources and implement joint research projects in areas from blockchain to genomics
Trilogue negotiations are underway on the European Health Data Space, which will enable cross-border sharing of data, including for research. Standardisation will be key to the plan’s success
The country will promote development of a transnational blockchain infrastructure for the storage and management of official documents, minister for digitisation Mathieu Michel tells Science|Business
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.